Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Myelin associated glycoprotein (MAG) is a transmembrane glycoprotein located on Schwann cells and oligodendrocytes adjacent to the myelin axon and acts between the colloid and axon. It belongs to the subgroup of sialic acid in the immunoglobulin superfamily and contains five immunoglobulin-like regions. MAG is divided into two subtypes, large and small, which have different expressions at different stages of myelination and maintenance. MAG plays a major role in the regeneration of peripheral nerves.
MAG Signal Transduction
The signal of MAG is not yet clear, but it was found to be mainly through the Rho /Rho kinase pathway. The Rho family is a class of guanosine triphosphate ase (GTP ase). Rho mediated activation of downstream effectors such as Rho-coupled kinase (ROCK), which in turn induces actin polymerization, ultimately leading to collapse of growth cones and inhibition of axon growth. The study also found that Rho inactivation or elevated cAMP levels in neurons, MAG-mediated inhibition will be blocked. Therefore, it is considered that the signal transduction pathway involved in Rho and cAMP is also required for MAG to exert an inhibitory effect, and the effects of the two are consistent with the MAG-mediated inhibitory effect.

Figure 1. Myelin inhibitors of axon regeneration. (Vajn, et al. 2013)
Development of MAG and PNS
In the peripheral nervous system (PNS) and the central nervous system (CNS), myelin sheath is composed of Schwann cells and some protein components, such as P0 protein, myelin basic egg white, peripheral myelin protein, myelin lipid protein and MAG. MAG is initially expressed in myelin sheath formation very early. MAG has already played its role in the initial stage of oligodendrocyte processes and axon interactions as well as in the stage of myelin sheath formation around axons through oligodendrocyte membrane and Schwann membrane. Evidence for MAG-promoting PNS myelin growth stems from studies of dorsal root ganglion (DRG) neurons and embryonic retinal neurons, and the results confirm that MAG promotes DRG neuron growth.
The Role of MAG after Peripheral Nerve Injury
Peripheral nerve injury can regenerate to a certain extent, but such regeneration occurs after Wallerian degeneration, that is, myelin is removed, Schwann cells return to the state of non-myelin and myelin protein expression decreases. The Rho /Rho kinase pathway is the signal transduction pathway of MAG, and Wallerian degeneration after nerve injury is related to the Rho /Rho kinase pathway to a certain extent. MAG accelerated axonal degeneration after the activation of Rho /Rho kinase in vitro experiments in the spinal cord. in vivo experiments, Wallerian denaturation can be blocked by RHO kinase inhibitors, while inhibiting Rho kinase activity in vivo and in vitro can delay Wallerian denaturation. However, RhoA activity was not detected in the injured sciatic axons, and the surface Rho/Rho kinase pathway in PNS was only one of the factors that accelerated Wallerian denaturation. Recent studies have found that topical application of MAG after sciatic nerve cutting can reduce the recovery of damage-promoting.
Studies have shown that chronic compression injury can stimulate the sprouting of axons. It also shows that in the chronic nerve compression injury of the nerve, the local MAG down-regulation is a major signal to the axon sprouting response. MAG has a positive regulation effect on the diameter of myelinated axons. The diameter of the axons surrounded by myelin in PNS of MAG-deficient mice is significantly reduced, which may be related to the decrease of neurofilament spacing and neurofilament phosphorylation, suggesting that mutations in the myelin gene may cause secondary changes in nerve cells.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.